Clinical Trials Browser

Phase 1/2 × NETWORK × Genitourinary × Clear all

NCT04851119 2026-05-05

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

CNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Melanoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Ewing, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Hepatoblastoma, Desmoid Tumors

NCT00003930 2020-10-20

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Phase 1/2 Completed

84 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT00002602 2020-01-10

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 1/2 Completed

1,084 enrolled

Genitourinary

Prostatic Neoplasms